NEXTECH VENTURE

nextech-venture-logo

Nextech Venture Fund is an early stage venture fund focussing on European early stage healthcare and information technology companies. With its unique oncology focused Fund II, Nextech Venture has become the dedicated investor for oncology companies. Nextech Venture profits from the support of an active, and committed Scientific Advisory Board of highly connected, and influential scientific oncology advisors. Nextech Venture organizes the Global Oncology Venture Event which is held annually in major cities around the globe. Nextech Venture is independent from any other institution, be it financial, industrial or private. Is a member of the European Private Equity, and Venture Capital Association EVCA,and the Swiss Private Equity, and Corporate Finance Association SECA.

#People #Financial #More

NEXTECH VENTURE

Social Links:

Founded:
1998-01-01

Status:
Active

Contact:
+41 (0)44 366 66 11

Email Addresses:
[email protected]


Current Employees Featured

daniel-hastik_image

Daniel Hastik
Daniel Hastik Partner / EIR @ Nextech Venture
Partner / EIR
2017-04-01

Investments List

Date Company Article Money raised
2009-08-10 Palyon Medical Nextech Venture investment in Series A - Palyon Medical 24 M USD
2008-10-23 MacroGenics Nextech Venture investment in Series D - MacroGenics 25 M USD
2008-09-10 ImVisioN Therapeutics Nextech Venture investment in Series A - ImVisioN Therapeutics 2.9 M EUR

More informations about "Nextech Venture"

Nextech Invest โ€“ Finding and fueling tomorrowโ€™s advances.

Finding and fueling tomorrowโ€™s advances in precision medicine. From our base in Zurich, Switzerland, we fuel the success of emerging biotechnology companies worldwide by โ€ฆSee details»

team โ€“ Nextech Invest

The Nextech difference. We fuse unrivaled worldwide scientific expertise with unmatched investment rigor to deliver for patients and investors. Meet our team.See details»

Nextech Venture - Crunchbase Investor Profile

Nextech Venture Fund is an early stage venture fund focussing on European early stage healthcare and information technology companies. With its unique oncology focused Fund II, Nextech Venture has become the dedicated โ€ฆSee details»

approach โ€“ Nextech Invest

Nextech is a global, cancer therapeutics-focused venture capital firm headquartered in Zurich, Switzerland. We focus almost exclusively on oncology therapeutics, and on helping to drive โ€ฆSee details»

Nextech Invest - LinkedIn

Nextech is a global, cancer therapeutics-focused venture capital firm headquartered in Zurich, Switzerland. We focus almost exclusively on oncology therapeutics, and on helping to drive value...See details»

Nextech Invest - Crunchbase Investor Profile & Investments

Nextech Invest is a venture capital and private equity firm specializing in early, mid-stage, late-stage, and emerging growth investments. The firm also invests in incorporation, spin-outs, โ€ฆSee details»

Nextech Ventures - Crunchbase Investor Profile

Nextech Ventures is a venture capital fund that invests in seed stage companies in the e-commerce, analytics, SaaS, and VR sectors.See details»

Nextech Invest - LinkedIn

Finding and fueling tomorrow's advances in precision medicine | Nextech is a global, cancer therapeutics-focused venture capital firm headquartered in Zurich, Switzerland. We focus โ€ฆSee details»

TPG to Acquire Leading Specialty Healthcare IT โ€ฆ

Jul 19, 2023ย ยท TPG is investing in Nextech through TPG Capital, its U.S. and European late-stage private equity platform. โ€œNextechโ€™s goal is to simplify the healthcare experience so physicians can focus on what matters most: their โ€ฆSee details»

Nextech Invest - EU-Startups

Nextech is a global, cancer therapeutics-focused venture capital firm headquartered in Zurich, Switzerland. We focus almost exclusively on oncology therapeutics, and on helping to drive โ€ฆSee details»

Nextech Ventures investment portfolio - PitchBook

Information on investments, active portfolio, exits, fund performance, dry powder, and co-investors for Nextech Ventures. Use the PitchBook Platform to explore the full profile.See details»

Nextech Invest investment portfolio - PitchBook

Founded in 1998, Nextech Invest is a venture capital investment firm based in Zurich, Switzerland. The firm seeks to invest in the life science, biotechnology, and oncology sectors โ€ฆSee details»

Nextech Invest - Investments, Portfolio & Company Exits

Nextech Invest is a venture capital and private equity firm specializing in early, mid-stage, late-stage, and emerging growth.See details»

Nextech V Oncology: Fund Performance - PitchBook

Jul 17, 2020ย ยท Nextech V Oncology is a 2018 vintage venture capital fund managed by Nextech Invest. The fund is located in Zurich, Switzerland and invests in the United States and Europe. โ€ฆSee details»

Nextech Venture - Private Equity List

Nextech is run by an experienced team of industry experts and supported by leading key opinion leaders in oncology. We deploy our expertise to invest equity in cancer companies with game โ€ฆSee details»

Nextech Invest - Private Equity List

Nextech is a global, cancer therapeutics-focused venture capital firm headquartered in Zurich, Switzerland. We focus almost exclusively on oncology therapeutics, and on helping to drive โ€ฆSee details»

Nextech Ventures - Investments, Portfolio & Company Exits

May 9, 2024ย ยท Nextech Ventures is a venture capital fund that invests in seed stage companies in the e-commerce, analytics, SaaS, and VR sectors.See details»

Nextech VI Oncology: Fund Performance - PitchBook

Mar 11, 2020ย ยท Nextech VI Oncology is a 2020 vintage venture capital fund managed by Nextech Invest. The fund is located in Zurich, Switzerland and it invests in oncology & life sciences. โ€ฆSee details»

Nextech Ventures - Crunchbase

Nextech Ventures is a venture capital fund that invests in seed stage companies in the e-commerce, analytics, SaaS, and VR sectors.See details»

NexTech Company Profile 2024: Valuation, Funding & Investors

Developer of electronic medical record and practice management software committed to improving the performance of specialty practices.See details»